Podcast Beta
Questions and Answers
Sativex is a medication derived from marijuana plants that can give users a 'high'.
False
The use of Sativex in hospitals has been common prior to the current trial.
False
Patients with terminal cancer are among the first to participate in the Sativex trial.
True
Sativex has undergone tests for quality, safety, and efficacy before being prescribed.
Signup and view all the answers
Sativex can be sprayed under the tongue up to 10 times a day.
Signup and view all the answers
Study Notes
Sativex Trial in Hospitals
- Patients at North Manchester General and Fairfield in Bury are participating in a trial using Sativex, a marijuana-derived medication.
- Sativex is a spray administered under the tongue up to 10 times daily.
- It aims to relieve pain by numbing muscles and does not produce a "high."
- The trial initially targets terminally ill cancer patients, with potential expansion to other conditions if successful.
- Sativex has been available in Britain for multiple sclerosis patients since last summer but is now being used in hospitals for the first time.
- The drug has undergone rigorous testing for quality, safety, and efficacy.
- Doctors are already prescribing Sativex for multiple sclerosis patients.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
This quiz covers the ongoing clinical trial of Sativex, a marijuana-derived medication being tested in hospitals for terminally ill cancer patients. It explores how Sativex works, its administration, and its potential to relieve pain without producing a high. Additionally, learn about its prior use in multiple sclerosis patients and the rigorous testing it has undergone.
